Who will benefit from vorasidenib? Review of data from the literature and open questions. Read more about Who will benefit from vorasidenib? Review of data from the literature and open questions.
Interventional neurorehabilitation for glioma patients: A systematic review. Read more about Interventional neurorehabilitation for glioma patients: A systematic review.
No drug holidays in BRAFV600E glioma patients: An argument for dose reduction of targeted therapies. Read more about No drug holidays in BRAFV600E glioma patients: An argument for dose reduction of targeted therapies.
Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study. Read more about Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study.
Neuro-oncology is a team sport: Is it time we added lifestyle coaches? Read more about Neuro-oncology is a team sport: Is it time we added lifestyle coaches?
Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions. Read more about Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions.
Inherited genetics of adult diffuse glioma and polygenic risk scores-a review. Read more about Inherited genetics of adult diffuse glioma and polygenic risk scores-a review.
Safe surgery for glioblastoma: Recent advances and modern challenges. Read more about Safe surgery for glioblastoma: Recent advances and modern challenges.
Categorizing continuous biomarkers: More cons than pros. Read more about Categorizing continuous biomarkers: More cons than pros.
Global comparison of awake and asleep mapping procedures in glioma surgery: An international multicenter survey. Read more about Global comparison of awake and asleep mapping procedures in glioma surgery: An international multicenter survey.
